"10.1371_journal.pone.0094059","plos one","2014-04-14T00:00:00Z","Sabine Kahl; Klaus Stra√üburger; Bettina Nowotny; Roshan Livingstone; Birgit Kl√ºppelholz; Kathrin Ke√üel; Jong-Hee Hwang; Guido Giani; Barbara Hoffmann; Giovanni Pacini; Amalia Gastaldelli; Michael Roden","Institute for Clinical Diabetology, German Diabetes Center at Heinrich-Heine University, D√ºsseldorf, Germany; Department of Endocrinology and Diabetology, Heinrich-Heine University D√ºsseldorf, D√ºsseldorf, Germany; Institute for Biometrics and Epidemiology, German Diabetes Center at Heinrich-Heine University, D√ºsseldorf, Germany; IUF ‚Ä Leibniz Research Institute for Environmental Medicine, D√ºsseldorf, Germany; National Research Council, Institute of Biomedical Engineering, Metabolic Unit, Padova, Italy; National Research Council, Institute of Clinical Physiology, Pisa, Italy; German Center for Diabetes Research, Partner D√ºsseldorf, Germany","Conceived and designed the experiments: MR SK BN KS BK RL JHH. Performed the experiments: SK BN RL KK BK. Analyzed the data: SK KS RL JHH GG BH GP AG MR. Contributed reagents/materials/analysis tools: KS JHH GP. Wrote the paper: SK KS RL JHH GG GP MR. Revision of article: SK KS BN RL BK KK JHH GG BH GP AG MR. Final approval: SK KS BN RL BK KK JHH GG BH GP AG MR.","Unrelated to this study, M. R. has financial relationships with Boehringer Ingelheim Pharma, Eli Lilly, Novartis Pharma GmbH, Novo Nordisk, Sanofi-Aventis Deutschland GmbH and Takeda Pharma Ges. mbH, Austria. B. N. had travel costs paid by Sanofi-Aventis Deutschland GmbH. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Sabine Kahl","SK",12,TRUE,7,5,9,7,TRUE,TRUE,FALSE,0,NA,FALSE
